TMCI Treace Medical Concepts Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TMCI

Price (delayed)

$3.655

Market cap

$237.11M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.96

Enterprise value

$296.94M

?
Relative Growth: Rel. Growth: 23
Relative Strength: Rel. Strength: 79
Relative Valuation: Rel. Valuation: 28
Relative Profitability: Rel. Profitability: 28

Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The ...

Highlights
The equity has declined by 27% year-on-year and by 12% since the previous quarter
Treace Medical Concepts's quick ratio has decreased by 26% YoY and by 19% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.treace.com
Peers: OFIX

Key stats

What are the main financial stats of TMCI

TMCI stock price

How has the Treace Medical Concepts stock price performed over time
Intraday
7.5%
1 week
18.67%
1 month
99.73%
1 year
-36.66%
YTD
49.18%
QTD
172.76%

Financial performance

How have Treace Medical Concepts's revenue and profit performed over time
Revenue
$207.32M
Gross profit
$165.27M
Operating income
-$55.74M
Net income
-$61.04M
Gross margin
79.7%
Net margin
-29.4%
TMCI's net margin is down by 17% YoY and by 6% QoQ
The company's net income fell by 15% YoY and by 3.5% QoQ
The operating margin is down by 8% YoY and by 5% QoQ
The operating income has contracted by 7% YoY and by 2.9% from the previous quarter

Price vs fundamentals

How does TMCI's price correlate with its fundamentals

Growth

What is Treace Medical Concepts's growth rate over time

Valuation

What is Treace Medical Concepts stock price valuation
P/E
N/A
P/B
3.06
P/S
1.14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.43
The EPS has declined by 13% year-on-year and by 3.2% since the previous quarter
TMCI's P/B is 67% below its 5-year quarterly average of 8.5 and 2.1% below its last 4 quarters average of 2.9
The equity has declined by 27% year-on-year and by 12% since the previous quarter
The P/S is 83% below the 5-year quarterly average of 6.3 and 12% below the last 4 quarters average of 1.2
TMCI's revenue is down by 2.5% QoQ

Efficiency

How efficient is Treace Medical Concepts business performance
The return on equity has declined by 43% year-on-year and by 12% since the previous quarter
Treace Medical Concepts's ROA has decreased by 28% YoY and by 6% from the previous quarter
Treace Medical Concepts's return on invested capital has decreased by 25% YoY and by 5% QoQ
The return on sales has declined by 19% year-on-year and by 6% since the previous quarter

Dividends

What is TMCI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TMCI.

Financial health

How did Treace Medical Concepts financials performed over time
TMCI's total assets is 72% greater than its total liabilities
Treace Medical Concepts's quick ratio has decreased by 26% YoY and by 19% QoQ
Treace Medical Concepts's current ratio has decreased by 20% YoY and by 17% from the previous quarter
TMCI's debt is 10% lower than its equity
The debt to equity has grown by 41% YoY and by 13% from the previous quarter
The equity has declined by 27% year-on-year and by 12% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.